https://www.medtechdive.com/news/noninvasive-magnetic-stimulation-for-ocd-wins-fda-nod/530432/
Noninvasive magnetic stimulation for OCD wins FDA nod | MedTech Dive
The agency's clearance for OCD is an extension of a 2008 approval of transcranial magnetic stimulation to treat major depression.
wins fda nodmagnetic stimulationnoninvasiveocdmedtech
https://www.drugdeliverybusiness.com/tandem-fda-clearance-aid-pregnancy-t1d/
Tandem wins FDA nod for AID in pregnancy with type 1 diabetes
Tandem Diabetes Care (Nasdaq:TNDM) today announced FDA clearance for its automated insulin delivery technology for use in pregnancy.
wins fda nodtandemaidpregnancytype
https://www.indianpharmapost.com/drug-approval/adma-biologics-wins-fda-nod-to-expand-asceniv-use-in-young-children-20116
ADMA Biologics wins FDA nod to expand ASCENIV use in young children
wins fda nodadmabiologicsexpanduse
https://www.medtechdive.com/news/JNJ-Monarch-FDA-clearance-Nvidia-GE-Healthcare/742370/
J&J’s Monarch robot wins FDA nod for AI software update | MedTech Dive
Using Nvidia and GE Healthcare technology, the robotic surgery system is intended to help doctors detect lung cancer earlier.
wins fda nodai softwaremonarchrobotupdate
https://www.medtechdive.com/news/Cleveland-Diagnostics-FDA-approval-prostate-cancer-test/806792/
Cleveland Diagnostics wins FDA nod for prostate cancer test | MedTech Dive
The IsoPSA test is intended to help assess whether patients with elevated PSA levels should go on to receive a biopsy procedure.
wins fda nodprostate cancerclevelanddiagnosticstest
https://pharma-industry-review.com/boehringers-hernexeos-wins-accelerated-fda-nod-in-lung-cancer
Boehringer’s HERNEXEOS® Wins Accelerated FDA Nod in Lung Cancer
Sep 15, 2025 - In a landmark decision for HER2-mutant lung cancer, the US FDA has granted accelerated approval to Boehringer Ingelheim’s HERNEXEOS® (zongertinib), the...
fda nodwinsacceleratedlungcancer